Marty Pagel
Researcher
Also affiliated: Monsanto (United States) (2006); DuPont (United States) (2001); German Cancer Research Center (2019); Pfizer (United States) (2005); Indiana University Bloomington (1997–2001); Institute on Aging (2024); Scripps MD Anderson Cancer Center (2024); DKFZ-ZMBH Alliance (2019); Toronto Metropolitan University (2019); Case Western Reserve University (2006)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Marty Pagel's research focuses on the application of advanced medical imaging techniques, particularly magnetic resonance imaging (MRI), to study disease mechanisms and therapeutic responses. His work involves developing and improving imaging methods, such as acidoCEST MRI, and utilizing machine learning to analyze imaging data. Pagel has investigated the use of MRI to monitor the effects of immunotherapy, specifically in mitigating tumor acidosis with agents like esomeprazole. He has also explored oxygen imaging in the context of tumor radiotherapy. Pagel has published 15 papers, accumulating approximately 500 citations, and holds an h-index of 9. His recent publications in 2023 and 2024 indicate ongoing activity in these research areas.
Metrics
- h-index: 9
- Publications: 15
- Citations: 500
Selected Publications
-
436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI (2024)
Collaboration Network
Top Collaborators
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
- 436 Immunotherapy Sensitization via Tumor Acidosis Mitigation by Esomeprazole Monitored with MRI
Similar Researchers
Based on overlapping research topics